top 300 drugs by class Flashcards
Acetaminophen 300mg / Codeine 30mg
Tylenol #3
Acetaminophen 300mg / Codeine 30mg (tylenol#3) class
Analgesic/opioid
Acetaminophen 300mg / Codeine 30mg (tylenol#3) dose
1-2 tab q4-6h (max 4g APAP/day)
limit use for 5 days for acute pain
3 days for fever
Acetaminophen 300mg / Codeine 30mg (tylenol#3) contraindications
children undergoing tonsillectomy/ adenoidectomy
caution G6PD deficiency
causes hepatotoxicity
[BBW] Acetaminophen–> acute liver failure, at times resulting in liver transplant and death
Acetaminophen 300mg / Codeine 30mg (tylenol#3) dose adjustment
Hepatic (APAP)
renal (codeine)
Acetaminophen (APAP) oral
Tylenol
Acetaminophen (tylenol, Ofirmev) class
analgesic
Acetaminophen PO (tylenol) dose
650mg q 4-6h (max 4g/day APAP)
Acetaminophen (APAP) IV
Ofirmev
Acetaminophen IV (ofirmev) dose
<50 kg: 12.5 mg/kg q4h
or 15 mg/kg q6 hrs; (max single dose: 15 mg/kg/dose) ; (max daily dose: 75 mg/kg/day)
≥50 kg: 650 mg q 4h
or 1,000 mg q6 h; (max single dose: 1,000 mg/dose); (max daily dose: 4 g/day)
Acetaminophen Contraindications
caution with G6PD deficiency
causes hepatotoxicity
[BBW] Acetaminophen –> acute liver failure, at times resulting in liver transplant and death
acetaminophen dose adjustment
hepatic
Aspirin
Aspirin
Aspirin class
analgesic, Salicylate, anti-platelet
Aspirin Acute coronary syndrome dose
initial: 162-325mg
maintenance: 81-325mg qd
Aspirin Analgesic and antipyretic dose
IR: 325-650mg prn q4h (max 4g/day) (((higher dose)))
Aspirin contraindications
Patients with:
- asthma
- rhinitis
- nasal polyps
Do not use in children or teenagers for viral infections with or without fever –> Reye Syndrome
Aspirin dose adjustment
renal
hepatic
Celecoxib
Celebrex
Celecoxib (Celebrex) class
analgesic, COX 2 selective, NSAID
Celecoxib (Celebrex) dose
100mg BID
or 200mg QD
Celecoxib (Celebrex) contraindication
Celecoxib (Celebrex) dose adjustment
renal
hepatic
Diclofenac PO
Cambia
Diclofenac Patch
Flector
Diclofenac Gel
Voltaren
Diclofenac (Cambia, Flector, Voltaren) class
analgesic, NSAID
Diclofenac PO (Cambia) dose
PO: 50mg 2-3x/d
Diclofenac patch (Flector) dose
Patch: apply 1 patch BID to most painful area
Diclofenac Gel (Voltaren) dose
Gel: apply 2-4g of 1% gel to affected areas 4x/d
Diclofenac (Cambia, Flector, Voltaren) contraindications
Diclofenac (Cambia, Flector, Voltaren) dose adjustment
renal
Fentanyl
Abstral, Duragesic, Fentora
Fentanyl (Abstral, Duragesic, Fentora) class
analgesic, opioid
Fentanyl (Abstral, Duragesic, Fentora) IV dose
IV: 50-100mcg LD with 25-50mcg/h titrated to pt need
Fentanyl (Abstral, Duragesic, Fentora) Transdermal dose
Transdermal: 25-100mcg/h
Fentanyl (Abstral, Duragesic, Fentora) contraindications
Life-threatening respiratory depression
Addiction, abuse, and misuse
Risk of concomitant use with benzodiazepines or other CNS depressants
Fentanyl (Abstral, Duragesic, Fentora) dose adjustment
renal
hepatic
Hydrocodone/ Acetaminophen
Norco, Vicodin, Lorcet
Hydrocodone/ Acetaminophen (Norco, Vicodin, Lorcet) class
analgesic, opioid
Hydrocodone/ Acetaminophen (Norco, Vicodin, Lorcet) dose
PO: Hydrocodone 2.5-10 mg Q 4-6h.
Max APAP <4g/day
Hydrocodone/ Acetaminophen (Norco, Vicodin, Lorcet) contraindications
Severe CNS depression
Severe respiratory depression
Hydrocodone/ Acetaminophen (Norco, Vicodin, Lorcet) dose adjustment
renal
hepatic
Hydromorphone
Diladud
Hydromorphone (Diladud) class
analgesic, opioid
Hydromorphone (Diladud) tablet dose
PO: Initial: 2-4 mg Q 4-6h prn (tablets)
parenteral doses are NOT equivalent; parenteral doses are up to 5 times more potent.
Opiate naïve (lower doses to start)
Hydromorphone (Diladud) contraindications
Hydromorphone (Diladud) dose adjustment
hepatic
renal
Hydromorphone (Diladud) oral solution dose
2.5 mg- 10 mg Q 3-6h prn (oral solution).
parenteral doses are NOT equivalent; parenteral doses are up to 5 times more potent.
Opiate naïve (lower doses to start)
Hydromorphone (Diladud) IV dose
IV: 0.2-1mg Q2-3h PRN
Ibuprofen
Motrin, Advil
Ibuprofen (Motrin, Advil) class
Analgesic, NSAID
Ibuprofen (Motrin, Advil) RX dose
400-800mg 3-4x/d (max 3200mg/d)
Ibuprofen (Motrin, Advil) contraindications
Concurrent use with ketorolac (NSAID) or pentoxifylline
Treatment of perioperative pain with CABG
Ibuprofen (Motrin, Advil) dose adjustment
renal
Ibuprofen (Motrin, Advil) OTC dose
200-400 mg Q 4-6h (max 1200mg/d)
Indomethacin
Indocin; Tivorbex
Indomethacin (Indocin; Tivorbex) class
analgesic, NSAID
Indomethacin (Tivorbex) acute pain dose
PO: 20mg TID
Indomethacin (Indocin; Tivorbex) ER dose
PO: ER 75mg QD-BID
Indomethacin (Indocin; Tivorbex) contraindications
IV administration with neonates
CABG surgery
History of asthma, urticarial
Indomethacin (Indocin; Tivorbex) dose adjustment
none
Ketoralac
Toradol
Ketoralac (Toradol) class
Analgesic, NSAID
Ketoralac (Toradol) dose
IV: 30mg single dose
or 30mg Q6h (120mg)
Ketoralac (Toradol) contraindications
NSAID –» High risk of bleeding, Active or history of peptic ulcer disease, Recent or history of GI bleeding or perforation, Concurrent ASA or other NSAID use
Patients with advanced renal disease or risk of renal failure
Prophylaxis before major surgery
Suspected or confirmed cerebrovascular bleeding
Hemorrhagic diathesis
Ketoralac (Toradol) dose adjustment
hepatic
renal
Lidocaine
Lidoderm, Xylocaine
Lidocaine (Lidoderm, Xylocaine) class
anesthetic analgesic, local antiarrhythmic class IB
Lidocaine (Lidoderm, Xylocaine) dose
Apply 4.5 mg/kg/day divided in four doses
Apply 5% patch to painful area for 12h QD
Lidocaine (Lidoderm, Xylocaine) contraindications
Use with caution in patients with known drug sensitivities
Accumulation of metabolites may be increased in renal dysfunction
Lidocaine (Lidoderm, Xylocaine) dose adjustment
hepatic
Meloxicam tablet
Mobic
Meloxicam caps
Vivlodex
Meloxicam ODT
Omiiz
Meloxicam (Mobic, Vivlodex, Qmiiz) class
Analgesic, COX2 Selective NSAID
Meloxicam (Mobic, Vivlodex, Qmiiz) dose
5-15mg daily (max 15 mg/day)
Meloxicam (Mobic, Vivlodex, Qmiiz) contraindications
Renal damage can occur (avoid use with severe impairment)
Increase in blood pressure (monitor)
Meloxicam (Mobic, Vivlodex, Qmiiz) dose adjustment
None
Methadone
Dolophine
Methadone (Dolophine) class
analgesic opioid
Methadone (Dolophine) pain management
PO dose
IV dose
detoxification dose
PO: 2.5mg Q8h
titrated increase to achieve stable dose
IV: 2.5-10mg Q 8-12h
detoxification: PO: titrate to about 40mg/d in divided doses to achieve stabilization
Methadone (Dolophine) contraindications
Methadone (Dolophine) dose adjustment
renal
Morphine
Duramorph, MS Contin
Morphine (Duramorph, MS Contin) class
analgesic opioid
Morphine (Duramorph, MS Contin) opioid-naive dose
IV: 2.5-5mg Q3-4h
Morphine (Duramorph, MS Contin) Epidural lumbar region dose
30-100mcg/kg as a single dose
Morphine (Duramorph, MS Contin) contraindications
Caution in both renal and liver impairment—monitor patients
Morphine (Duramorph, MS Contin) dose adjustment
none
Naproxen
Naprosyn, Aleve
Naproxen (Naprosyn, Aleve) class
analgesic, NSAID
Naproxen (Naprosyn, Aleve) dose
250-750mg BID (max1500mg/kg)
Naproxen (Naprosyn, Aleve) contraindications
Renal damage can occur (avoid use with severe impairment)
Increase in blood pressure (monitor)
Naproxen (Naprosyn, Aleve) dose adjustment
renal
oxycodone
OxyContin
oxycodone (OxyContin) class
analgesic opioid
oxycodone (OxyContin) IR initial dose
IR: 5-15mg Q4-6h prn (range 5-20mg/dose)
oxycodone (OxyContin) opioid-naive dose
ER tab
ER caps
ER tab: 10mg Q12h
ER caps: 9mg Q12h
ER caps not equivalent to ER tab
oxycodone (OxyContin) contraindications
Severe CNS depression
Severe respiratory depression
oxycodone (OxyContin) dose adjustment
renal
hepatic
Oxycodone/ Acetaminophen
Endocet, Percocet
Oxycodone/ Acetaminophen (Endocet, Percocet) class
analgesic/ opioid comb
Oxycodone/ Acetaminophen (Endocet, Percocet) dose
IR
ER
IR: 5mg moderate pain
10 mg severe pain
ER: 2 tab Q12h the second initial dose may be administered as early as 8 hours after the first initial dose if needed
(Do not exceed 4 g/day of acetaminophen)
Oxycodone/ Acetaminophen (Endocet, Percocet) contraindications
Swallow oxycodone/acetaminophen ER whole; crushing, chewing, or dissolving ER can cause rapid release and absorption of a potentially fatal dose of oxycodone
Oxycodone/ Acetaminophen (Endocet, Percocet) dose adjustment
hepatic
renal
Phenazopyridine
Azo, Pyridium
Phenazopyridine (Azo, Pyridium) class
urinary analgesic
Phenazopyridine (Azo, Pyridium) RX dose
200mg TID after meals for 2 days
Phenazopyridine (Azo, Pyridium) OTC dose
190mg TID with or after meals up to 2 days
Phenazopyridine (Azo, Pyridium) contraindications
Reddish-orange discoloration of the urine occurs.
Drug should be discontinued if skin or sclera develop a yellow color (may indicate drug accumulation due to impaired renal excretion).
Phenazopyridine (Azo, Pyridium) dose adjustment
renal
promethazine/ codeine
Phenergan with Codeine
promethazine/ codeine (Phenergan with Codeine) class
analgesic, opioid, antitussive, H1 antagonist 1st generation
promethazine/ codeine (Phenergan with Codeine) dose
PO: 5ml (Promethazine 6.25/10 mg codeine) Q4-6h (max 30ml/d)
promethazine/ codeine (Phenergan with Codeine) contraindications
Coma or CNS depressants
Altered cardiac conduction
Anticholinergic side effects
Extrapyramidal symptoms
promethazine/ codeine (Phenergan with Codeine) dose adjustment
renal
hepatic
Tramadol
Ultram
Tramadol (Ultram) class
analgesic
Tramadol (Ultram) dose
25-100mg Q4-6h prn (400mg/d)
Tramadol (Ultram) contraindications
Paralytic ileus
Severe respiratory depression
Drug abuse and dependence
Increase risk of seizures
Serotonin syndrome
Tramadol (Ultram) dose adjustment
hepatic
renal
Bubprenorphine/ naloxone
Suboxone, Bunavail, Zubsoly
Buprenorphine/ naloxone (Suboxone, Bunavail, Zubsoly) class
opioid partial agonist/antagonist
Buprenorphine/ naloxone (Suboxone) dose
initial: sublingual: Buprenorphine 2mg/ naloxone 0.5mg
or
Buprenorphine 4mg/ naloxone 1 mg
may titrate dose
Buprenorphine/ naloxone (Suboxone, Bunavail, Zubsoly) contraindications
CNS and respiratory depression (opioid)
Avoid for severe hepatic dysfunction
Buprenorphine/ naloxone (Suboxone, Bunavail, Zubsoly) dose adjustment
hepatic
Naloxone
Eyzio, Narcan
Naloxone (Eyzio, Narcan) class
opioid antagonist
Naloxone (Eyzio, Narcan) dose
opioid overdose IV, IM, SQ
Intranasal
IV, IM, SubQ: Initial 0.4 -2 mg Q 2 -3 minutes up to 10 mg total
Intranasal: 4 mg (1 spray) as single dose in one nostril. May repeat in 3-5 min if respiratory depression persists
Naloxone (Eyzio, Narcan) dose adjustment
none
Acyclovir
zovirax
Acyclovir (zovirax) class
antiviral
Acyclovir (zovirax) dose
PO
IV
Shingles
800mg 5 x/day for 7-10 days.
Initiate at earliest sign or symptom; most effective when initiated ≤72 hours after rash onset
IV: 10-15 mg/kg/dose q8h for 10-14 days
Acyclovir (zovirax) contraindications
neurotoxicity esp with renal failure
Acyclovir (zovirax) dose adjustment
renal
Oseltamivir
Tamiflu
Oseltamivir (Tamiflu) class
antiviral
Oseltamivir (Tamiflu) dose
Prophylaxis: 75 mg QD
Treatment: 75 mg BID
Oseltamivir (Tamiflu) dose adjustment
renal
Valacyclovir
Valterx
Valacyclovir (Valterx) class
antiviral
Valacyclovir (Valterx) dose
Treatment, initial episode:
PO: 1 g BID for 7-10 days
Treatment, recurrent episode: PO: 500 mg BID for 3 days
or 1 g QD for 5 days.
Suppressive therapy (eg, for severe and/or frequent recurrences): PO: 500 mg or 1 g QD
Valacyclovir (Valterx) contraindications
CNS AEs
Valacyclovir (Valterx) dose adjustment
renal
Alendronate
Fosamax, Binosto
Alendronate (Fosamax, Binosto) class
Bisphosphonate
Alendronate (Fosamax, Binosto) dose
Prophylaxis: 5mg qd or 35mg q wk
treatment: 10mg qd or 70mg q wk
Alendronate (Fosamax, Binosto) contraindications
Esophageal abnormalities or high risk for adverse esophageal effects
Hypocalcemia
Inability to sit or stand upright for at least 30 minutes
Atypical femur fractures
Alendronate (Fosamax, Binosto) dose adjustment
renal
Ibandronate
Boniva
Ibandronate (Boniva) class
Bisphosphonate
Ibandronate (Boniva) dose
PO
IV
PO: 150mg Q month
IV: 3mg Q 3 months
Ibandronate (Boniva) contraindications
Esophageal abnormalities or high risk for adverse esophageal effects
Hypocalcemia
Inability to sit or stand upright for at least 30 minutes
Ibandronate (Boniva) dose adjustment
renal
Risedronate
Actonel
Risedronate (Actonel) class
Bisphosphonate
Risedronate (Actonel) dose
IR
DR
IR: Prevention and treatment: 5 mg QD or 35 mg Q wk or 150 mg Q month
DR: 35 mg Q wk
Risedronate (Actonel) contraindications
Esophageal abnormalities which delay esophageal emptying
Hypocalcemia
Inability to sit or stand for 30 minutes
Atypical femur fractures
Osteonecrosis of the jaw
Risedronate (Actonel) dose adjustments
renal
Alprazolam
Xanax
Alprazolam (Xanax) class
BDZ
Alprazolam (Xanax) dose
IR
ER
IR: 0.25-0.5 mg 3x/d (max 4mg/day)
ER: 0.5 -1 mg QD; titrate dose every 3 to 4 days in increments ≤1 mg/day (range: 3 to 6 mg/day)
Alprazolam (Xanax) contraindications
Benzodiazepines have been associated with anterograde amnesia
Alprazolam (Xanax) dose adjustment
hepatic
Clonazepam
Klonopin
Clonazepam (Klonopin) class
BDZ
Clonazepam (Klonopin) dose
0.25-2mg BID (max 4mg/day)
Clonazepam (Klonopin) contraindications
Anterograde amnesia
CNS depression
Potential for abuse
Clonazepam (Klonopin) dose adjustment
none
Diazepam
Valium, Diastat (rectal)
Diazepam (Valium, Diastat (rectal)) class
BZD
Diazepam (Valium, Diastat (rectal)) dose
PO, IM,IV
rectal
Anxiety
PO, IM, IV: 2-10 mg 2-4x/ day PRN
(note: IM has erratic absorption and is not recommended)
Rectal: 0.2-0.5 mg/kg (max 20 mg)
Diazepam (Valium, Diastat (rectal)) contraindications
Anterograde amnesia
Drug abuse potential
Diazepam (Valium, Diastat (rectal)) dose adjustments
hepatic
Lorazepam
Ativan
Lorazepam (Ativan) class
BDZ
Lorazepam (Ativan) dose
PO
IV
Anxiety
PO: 2-6mg in divided doses (10 mg/day)
Agitation
IV: 0.02-0.06 mg/kg every 2-6 hours
Lorazepam (Ativan) contraindications
Severe respiratory depression
Abuse potential
Lorazepam (Ativan) dose adjustment
hepatic
Midazolam
Nayzilam (nasal)
Midazolam (Nayzilam) class
BDZ
Midazolam (Nayzilam) dose
Pre-op sedation
seizures
Pre-op sedation
IV: 0.1 to 0.35 mg/kg over 20 to 30 seconds
Seizures (nasal): 5 mg (one spray) as a single dose in one nostril; may repeat dose in 10 minutes in alternate nostril based on response and tolerability
Midazolam (Nayzilam) contraindications
Anterograde amnesia
Midazolam (Nayzilam) dose adjustments
none
Temazepam
Restoril
Temazepam (Restoril) class
BDZ
Temazepam (Restoril) dose
7.5-30mg at bedtime
Temazepam (Restoril) contraindications
Pregnancy
Benzodiazepines have been associated with anterograde amnesia
Temazepam (Restoril) dose adjustment
none
Trazodone
Deseryl
Trazodone (Deseryl) class
antidepressant, SSRI
Trazodone (Deseryl) dose
Insomnia
25mg-200mg at bedtime
Trazodone (Deseryl) contraindications
Serotonin syndrome
Prolongs the QT/QTc interval
Trazodone (Deseryl) dose adjustment
none
Vilazodone
Viibryd
Vilazodone (Viibryd) class
antidepressant SSRI
Vilazodone (Viibryd) dose
10mg QD for 7days
then increase to 20 then 40 QD
Vilazodone (Viibryd) contraindications
Serotonin syndrome
Vilazodone (Viibryd) dose adjustment
none
Escitalopram
Lexapro
Escitalopram (Lexapro) class
antidepressant, SSRI
Escitalopram (Lexapro) dose
10-20mg QD (max 20mg/day)
Escitalopram (Lexapro) contraindications
[BBW]Antidepressants increase the risk of suicidal thinking and behavior in children, adolescents, and young adults
Potentially life-threatening serotonin syndrome has occurred with serotonergic agents
Escitalopram (Lexapro) dose adjustment
renal
hepatic
Fluoxetine
Prozac, Sarafem
Fluoxetine (Prozac, Sarafem) class
antidepressant, SSRI
Fluoxetine (Prozac, Sarafem) dose
5-20 mg QD (max 80mg/day)
Fluoxetine (Prozac, Sarafem) contraindications
Potentially life-threatening serotonin syndrome (SS) has occurred with serotonergic agents
When discontinuing antidepressant treatment that has lasted for >3 weeks, gradually taper the dose
Fluoxetine (Prozac, Sarafem) dose adjustment
hepatic
Paroxetine
Paxil
Paroxetine (Paxil) class
antidepressant, SSRI
Paroxetine (Paxil) dose
IR
CR
Depression
IR: 20 mg QD; may increase dose based on response and tolerability in increments of 10 to 20 mg/day at intervals ≥1 week to a maximum of 50 mg/day
CR: 25 mg QD; may increase based on response and tolerability in increments of 12.5 mg/day at intervals ≥1 week to a maximum of 62.5 mg/day
Paroxetine (Paxil) contraindications
Potentially life-threatening serotonin syndrome (SS) has occurred with serotonergic agents
When discontinuing antidepressant treatment that has lasted for >3 weeks, gradually taper the dose
Discontinuing paroxetine or switching to another antidepressant unless the benefits of therapy justify continuing treatment during pregnancy
Paroxetine (Paxil) dose adjustment
renal
hepatic
Sertraline
Zoloft
Sertraline (Zoloft) class
antidepressant, SSRI
Sertraline (Zoloft) dose
Depression
50-100mg/day (max 200mg/day)
Sertraline (Zoloft) contraindications
Potentially life-threatening serotonin syndrome (SS) has occurred with serotonergic agents
When discontinuing antidepressant treatment that has lasted for >3 weeks, gradually taper the dose
Sertraline (Zoloft) dose adjustment
hepatic
Citalopram
Celexa
Citalopram (Celexa) class
antidepressant, SSRI
Citalopram (Celexa) dose
Depression:
10-40 mg daily
Due to the risk of QT prolongation, the maximum recommended daily dose for all indications is 40 mg. A lower maximum daily dose of 20 mg is recommended in patients >60 years of age, those with significant hepatic impairment, and patients who are concurrently receiving medications that significantly increase citalopram levels (eg, cimetidine, omeprazole) or known poor metabolizers of CYP2C19 substrates
Citalopram (Celexa) contraindications
Potentially life-threatening serotonin syndrome (SS) has occurred with serotonergic agents
Avoid use in CYP2C19 poor metabolizers
Citalopram (Celexa) dose adjustment
hepatic
renal
Desvenlafaxine
Pristiq, Khedezla
Desvenlafaxine (Pristiq, Khedezla) class
SNRI
Desvenlafaxine (Pristiq, Khedezla) dose
25-50 mg daily (some studies support titration up to 400 mg daily)
When discontinuing antidepressants that has lasted for >3 weeks, gradually taper the dose (eg, over 2 to 4 weeks) to minimize withdrawal symptoms
Desvenlafaxine (Pristiq, Khedezla) contraindications
Serotonin syndrome
Desvenlafaxine (Pristiq, Khedezla) dose adjustment
renal
hepatic
Venlafaxine
Effexor
Venlafaxine (Effexor ) class
SNRI
Venlafaxine (Effexor )dose
Depression
37.5-75mg QD (225mg/day)
Venlafaxine (Effexor ) contraindications
Serotonin syndrome
Venlafaxine (Effexor ) dose adjustment
hepatic
renal
Duloxetine
Cymbalta
Duloxetine (Cymbalta) class
antidepressant, SNRI
Duloxetine (Cymbalta) dose
30-60mg QD (max 120mg/day)
Duloxetine (Cymbalta) contraindications
Concurrent use of MAOI, TCA, or linezolid
Duloxetine (Cymbalta) dose adjustment
hepatic
renal
Amitriptyline
Amitriptyline
Amitriptyline class
Antidepressant, TCA
Amitriptyline dose
Depression:
25-50 mg QD at bedtime or in divided doses,
can gradually increase to 100-300 mg daily
Amitriptyline contraindications
Abrupt discontinuation or interruption of antidepressant therapy has been associated with a discontinuation syndrome
Use with caution in patients with a history of cardiovascular disease; the risk of conduction abnormalities with this agent is high relative to other antidepressants
Use with caution in patients at risk of seizures, including those with a history of seizures, head trauma, brain damage, alcoholism, or concurrent therapy with medications which may lower seizure threshold
Amitriptyline dose adjustment
none
Nortriptyline
Pamelor
Nortriptyline (Pamelor) class
antidepressant, TCA
Nortriptyline (Pamelor) dose
Depression
25mg 3-4x/day
(150mg/day)
Nortriptyline (Pamelor) contraindications
Abrupt discontinuation or interruption of antidepressant therapy has been associated with a discontinuation syndrome
Use with caution in patients with a history of cardiovascular disease; the risk of conduction abnormalities with this agent is high relative to other antidepressants
Use with caution in patients at risk of seizures, including those with a history of seizures, head trauma, brain damage, alcoholism, or concurrent therapy with medications which may lower seizure threshold
Nortriptyline is metabolized hepatically; use with caution
Nortriptyline (Pamelor) dose adjustment
none
Bupropion
Wellbutrin, Frofivo, Aplenzin (hydrobromide salt)
Bupropion (Wellbutrin, Frofivo, Aplenzin (hydrobromide salt)) class
antidepressant, dopamine reuptake inhibitor
Bupropion (Wellbutrin, Frofivo, Aplenzin (hydrobromide salt)) dose
150mg daily (max 450mg/day) for HCl salt
conversions available for hydrobromide salt
Bupropion (Wellbutrin, Frofivo, Aplenzin (hydrobromide salt)) contraindications
May cause a dose-related risk of seizures. Use is contraindicated in patients with a history of seizures or certain conditions with high seizure risk
Bupropion (Wellbutrin, Frofivo, Aplenzin (hydrobromide salt)) dose adjustment
hepatic
renal
Mirtazapine
Remeron
Mirtazapine (Remeron) class
Antidepressant, alpha 2 antagonist
Mirtazapine (Remeron) dose
MDD:
15mg QD at bedtime
increase dose in 15mg increments at intervals no less than Q 1-2wks (45mg/day)
Mirtazapine (Remeron) contraindications
Mirtazapine (Remeron) dose adjustment
none
Buspirone
Buspirone
Buspirone class
Anti anxiety agent
Buspirone dose
10-15mg/day in 2-3 divided doses
max 60mg/day
Buspirone contraindications
Potentially life-threatening serotonin syndrome has occurred with serotonergic agents, including buspirone, particularly when used in combination with other serotonergic agents (eg, triptans, TCAs, fentanyl, lithium, tramadol, buspirone, St John’s wort, tryptophan) or agents that impair metabolism of serotonin (eg, MAOIs intended to treat psychiatric disorders, other MAOIs [ie, linezolid and IV methylene blue])
Buspirone dose adjustment
renal
hepatic
Amiodarone PO
Pacerone
Amiodarone IV
Nexterone
Amiodarone PO (Pacerone, Nexterone) class
antiarrhythmic class III
Amiodarone PO (Pacerone) dose
PO: 200-1600 mg/day in 1-2 divided doses
Amiodarone IV (Nexterone) dose
IV: 150-300mg infused over 10 min
Amiodarone PO (Pacerone, Nexterone) contraindications
Hypersensitivity to iodine
BBW:
Hepatotoxicity (may be fatal). Obtain baseline and periodic liver transaminases and discontinue or reduce dose if the increase exceeds 3 times normal or doubles in a patient with an elevated baseline
Amiodarone PO (Pacerone, Nexterone) dose adjustment
hepatic
Digoxin
Lanoxin, Digitek
Digoxin (Lanoxin, Digitek) class
cardiac glycoside, antiarrhythmic class IV
Digoxin (Lanoxin, Digitek) dose
PO:0125-0.25mg QD
Total digitalizing dose: Initial: IV: 0.25 to 0.5 mg over several minutes, with repeat doses of 0.25 mg every 6 hours to a maximum of 1.5 mg over 24 hours
Digoxin (Lanoxin, Digitek) contraindications
Correct electrolyte disturbances, especially hypokalemia or hypomagnesemia, prior to use and throughout therapy
Digoxin (Lanoxin, Digitek) dose adjustment
renal
Verapamil
Calan SR, Verelan, Verelan PM
Verapamil (Calan SR, Verelan, Verelan PM) class
antihypertensive, CCB antiarrhythmic, class IV
Verapamil (Calan SR, Verelan, Verelan PM) dose
IR
SR
IV
PO: IR: 80-160mg 3x/day
SR: 180-480mg QD
IV: 2.5-10mg over 2 min, repeat if necessary
Verapamil (Calan SR, Verelan, Verelan PM) contraindications
Due to its negative inotropic and chronotropic effects, use is generally avoided in patients:
1- taking a BB
2- HFrEF
3- sinus node dysfunction, or 2nd or 3rd degree AV block unless a functioning pacemaker has been placed
Verapamil (Calan SR, Verelan, Verelan PM) dose adjustment
hepatic
Amlodipine
Norvasc
Amlodipine (Norvasc) class
antihypertensive, CCB
Amlodipine (Norvasc) dose
PO:2.5-10mg QD
Amlodipine (Norvasc) contraindications
The most common side effect is peripheral edema; occurs within 2 to 3 weeks of starting therapy
Amlodipine (Norvasc) dose adjustment
hepatic
Diltiazem
Cardizem, Cartia, Dilt-CD
Diltiazem (Cardizem, Cartia, Dilt-CD) class
antihypertensive, CCB
Diltiazem (Cardizem, Cartia, Dilt-CD) dose
PO
IV
PO:60-360mg QD or BID depending on dosage form
(480 mg/day)
IV continuous infusion: 5-10 mg/hr; may increase up to 15 mg/hr PRN
Diltiazem (Cardizem, Cartia, Dilt-CD) contraindications
Due to its negative inotropic and chronotropic effects, use is generally avoided in patients:
1- taking a BB
2- HfrEF
3- sinus node dysfunction or 2nd or 3rd degree AV block UNLESS a functioning pacemaker has been placed
Diltiazem (Cardizem, Cartia, Dilt-CD) dose adjustment
hepatic
Nifedipine
Procardia, Adalet
Nifedipine (Procardia, Adalet) class
antihypertensive, CCB
Nifedipine (Procardia, Adalet) dose
ER: 30-60mg daily (120-180 mg/day)
Nifedipine (Procardia, Adalet) contraindications
Concurrent use with strong CYP3A4 inducers
Cardiogenic shock
ST-elevation MI
Avoid use with cirrhosis
Nifedipine (Procardia, Adalet) dose adjustment
none
Olmesartan
Benicar
Olmesartan (Benicar) class
antihypertensive/ CHF, ARB
Olmesartan (Benicar) dose
20-40 QD
Olmesartan (Benicar) contraindications
pregnancy
History of angioedema
concurrent use of aliskiren
Olmesartan (Benicar) dose adjustment
renal
Valsartan
Diovan
Valsartan (Diovan) class
antihypertensive/CHF, ARB
Valsartan (Diovan) dose
40-160mg QD or BID (320mg/day)
Valsartan (Diovan) contraindications
pregnancy
History of angioedema
concurrent use of aliskiren
Valsartan (Diovan) dose adjustment
none
Irbesartan
Avapro
Irbesartan (Avapro) class
Antihypertensive/CHF, ARB
Irbesartan (Avapro) dose
PO:150-330 QD
Irbesartan (Avapro) contraindications
pregnancy
concurrent use of aliskiren
Irbesartan (Avapro) dose adjustment
renal
Losartan
Cozaar
Losartan (Cozaar) class
antihypertensive/CHF, ARB
Losartan (Cozaar) dose
PO: 50mg QD (100mg/day)
Losartan (Cozaar) contraindications
pregnancy
History of angioedema
concurrent use of aliskiren
Losartan (Cozaar) dose adjustment
hepatic
Sacubitril/valsartan
Entresto
Sacubitril/valsartan (Entresto) class
CHF, ARNI
Sacubitril/valsartan (Entresto) dose
PO:24/26mg, 49/52mg, 97/103mg BID
Sacubitril/valsartan (Entresto) contraindications
Concomitant use of (ACE) inhibitor is contraindicated; allow a 36-hour washout period when switching from or to an ACE inhibitor
concomitant use of aliskiren
angioedema
hyperkalemia
Sacubitril/valsartan (Entresto) dose adjustment
renal
hepatic
Benazepril
Lotensin
Benazepril (Lotensin) class
Antihypertensive, CHF, ACE-I
Benazepril (Lotensin) dose
5-40mg in 1 or 2 daily doses
Benazepril (Lotensin) contrainidcations
History of angioedema
Contraindicated in pregnancy
Benazepril (Lotensin) dose adjustment
renal
Enalapril
Enalaprilat IV
Vasotec, Epand (oral solution)
Enalapril (Vasotec, Epand (oral solution))
Enalaprilat IV
class
antihypertensive, CHF, ACE-I
Enalapril (Vasotec, Epand (oral solution))
Enalaprilat IV
doses
PO: 2.5-40mg QD
IV: 1.25mg/ dose over 5 min Q6h up to 5mg/dose
Enalapril (Vasotec, Epand (oral solution))
Enalaprilat IV contraindications
History of angioedema
Contraindicated in pregnancy
Enalapril (Vasotec, Epand (oral solution))
Enalaprilat IV dose adjustment
renal
Lisinopril
Zestril, Prinivil
Lisinopril (Zestril, Prinivil) class
antihypertensive, CHF, ACE-I
Lisinopril (Zestril, Prinivil) dose
HTN
CHF
HTN: PO: 10-40mg QD
CHF: PO: 20-40mg QD
Lisinopril (Zestril, Prinivil) contraindications
History of angioedema
Contraindicated in pregnancy
concurrent use of aliskiren
Lisinopril (Zestril, Prinivil) dose adjustment
renal
Ramipril
Altace
Ramipril (Altace) class
Antihypertensive, CHF, ACE-I
Ramipril (Altace) dose
1.5-5mg QD (20mg/day)
Ramipril (Altace) contraindications
History of angioedema
Contraindicated in pregnancy
concurrent use of aliskiren
Ramipril (Altace) dose adjustment
renal
Carvedilol
Coreg
Carvedilol (Coreg) class
antihypertensive, CHF, BB
Carvedilol (Coreg) dose
IR
ER
CHF
IR: 3.125-50mg BID
ER: 10-80mg QD
Carvedilol (Coreg) contraindications
BB therapy should not be withdrawn abruptly (particularly in patients with CAD), but gradually tapered to avoid acute tachycardia, hypertension, and/or ischemia
Carvedilol (Coreg) dose adjustment
hepatic
Labetalol
Labetalol, formerly Trandate, Normodyne
Labetalol ( formerly Trandate, Normodyne) class
antyhypertensive, BB
Labetalol ( formerly Trandate, Normodyne) dose
PO
IV
PO: 100mg BID up to 200-800mg BID
IV: 10-20mg IV push over 2 min at 10 min intervals until target SBP. 80mg/daily
Labetalol ( formerly Trandate, Normodyne) contraindications
Severe Bradycardia
Heart Block greater than first degree
Cardiogenic Shock
Bronchial asthma
Uncompensated cardiac failure
Beta-blocker therapy should not be withdrawn abruptly
Labetalol ( formerly Trandate, Normodyne) dose adjustment
none
Nebivolol
Bystolic
Nebivolol (Bystolic) class
antihypertensive, BB
Nebivolol (Bystolic) dose
5 QD (40mg)
Nebivolol (Bystolic) contraindications
Severe bradycardia
2nd or 3rd AV block
Decompensated heart failure
Severe hepatic impairment
Nebivolol (Bystolic) dose adjustment
hepatic
renal
Propranolol
Inderal
Propranolol (Inderal) class
antihypertensive, BB
Propranolol (Indral) dose
PO
IV
PO: IR: 40-320mg/day
IV: 1-3mg bolus (640mg/day)
Propranolol (Indral) contraindications
Severe sinus bradycardia
Uncompensated CHF
Beta-blocker therapy should not be withdrawn abruptly
Propranolol (Indral) dose adjustment
none
Bisoprolol
Bisoprolol
Bisoprolol class
Antihypertensive, CHF, BB, B1 selective
Bisoprolol dose
PO: initial 2.5-5mg (max 20mg/day)
Bisoprolol contraindications
Cardiogenic shock, cardiac failure, or first degree heart block, sinus bradycardia
Beta-blocker therapy should not be withdrawn abruptly
Bisoprolol dose adjustment
renal
hepatic
Metoprolol succinate
Toprol XL
Metoprolol succinate (Toprol) class
antihypertensive, CHF, BB, B1 selective
Metoprolol succinate (Toprol) dose
PO:50-100mg QD (400mg/day)
Metoprolol succinate (Toprol) contraindications
Severe bradycardia 2nd or 3rd degree AV block
Decompensated heart failure
Metoprolol succinate (Toprol) dose adjustment
hepatic
Metoprolol Tartrate
Lopressor
Metoprolol Tartrate (Lopressor) class
antihypertensive, BB, B1 selective
Metoprolol Tartrate (Lopressor) dose
PO
IV
PO: 25-100mg BID
(200mg/day)
IV: 1.25-5 mg Q 6-12 hours
(450 mg/day)
Metoprolol Tartrate (Lopressor) contraindications
Severe bradycardia 2nd or 3rd degree AV block
Decompensated heart failure
Metoprolol Tartrate (Lopressor) dose adjustment
hepatic
Atenolol
Tenormin
Atenolol (Tenormin) class
antihypertensive, BB, selective
Atenolol (Tenormin) dose
25-100mg QD
Atenolol (Tenormin) contraindications
Severe sinus bradycardia
Uncompensated CHF
Beta-blocker therapy should not be withdrawn abruptly
Atenolol (Tenormin) dose adjustment
renal
Clonidine
Catapres, Duraclon “Epidural”, Kapvay
Clonidine (Catapres, Duraclon “Epidural”, Kapvay) class
antihypertensive, alpha 2 adrenergic agonist
Clonidine (Catapres, Duraclon “Epidural”, Kapvay) dose
PO: 0.1-0.2 mg BID (max 2.4mg/day)
Transdermal patch: 0.1-0.3mg once weekly
Clonidine (Catapres, Duraclon “Epidural”, Kapvay) contraindication
Do not discontinue therapy abruptly. When discontinuing, taper gradually to decrease risk of rebound hypertension
Clonidine (Catapres, Duraclon “Epidural”, Kapvay) dose adjustment
none
Dxazosin
Cardura
Dxazosin (Cardura) class
antihypertensive, alpha 1 blocker
Dxazosin (Cardura) dose
IR: 1 mg daily titrated up to 8 mg/day
ER: 4 mg daily titrated up to 8 mg/day
Dxazosin (Cardura) contraindication
Do not use in severe hepatic impairment (Child-Pugh class C)
May cause orthostatic hypotension and syncope within a few hours after dosing, but may occur later; anticipate a similar effect if therapy is interrupted for a few days, if dosage is increased, or if another antihypertensive drug, PDE-5 inhibitor, or nitrates are introduced. Use with caution in patients with symptomatic orthostatic hypotension
Dxazosin (Cardura) dose adjustment
none
Trazosin
Formerly known as Hytrin
Trazosin (Formerly known as Hytrin) class
antihypertensive, alpha1 antagonist
Trazosin (Formerly known as Hytrin) dose
1mg daily at bedtime (20mg/day)
Trazosin (Formerly known as Hytrin) contraindication
Floppy iris syndrome
Hypotension/syncope
Trazosin (Formerly known as Hytrin) dose adjustment
none
Tamsulosin
Flomax
Tamsulosin (Flomax) class
Alpha-1 antagonist
Tamsulosin (Flomax) dose
0.4 mg daily ½ hour after the same meal each day
Max 0.8mg daily
Tamsulosin (Flomax) contraindications
Angina
Floppy iris syndrome
Orthostatic hypotension/syncope
Tamsulosin (Flomax) dose adjustment
none
Hydralazine
Apresoline
Hydaralazine (Apresoline) class
Antihypertensive, vaodilator
Hydaralazine (Apresoline) dose
CHF: initial 25-50mg 3-4x/day in combination with isosorbide dinitrate 3 or 4 times daily (300 mg/day)
Hydaralazine (Apresoline) contraindications
Coronary Artery disease
May cause a drug-induced lupus-like syndrome
Hydaralazine (Apresoline) dose adjustment
none
Amoxicillin
Amoxicillin
Amoxicillin class
antibiotic, PCN
Amoxicillin dose
PO: 500mg-1g Q8-12h
Amoxicillin contraindications
A high percentage of patients with infectious mononucleosis develop an erythematous rash during amoxicillin therapy; avoid use in these patients
Amoxicillin dose adjustment
renal
Amoxicillin/potassium clavulanate
Augmentin
Amoxicillin/potassium clavulanate (Augmentin) class
antibiotic, PCN
Amoxicillin/potassium clavulanate (Augmentin) dose
IR
ER
PO:
IR: 500mg Q8h
or 875mg Q12h
ER:2g Q12h
Amoxicillin/potassium clavulanate (Augmentin) contraindications
differing content of clavulanic acid, not all formulations are interchangeable;
use of an inappropriate product –>
diarrhea
or subtherapeutic clavulanic acid concentrations
–> decreased clinical efficacy.
Some products contain
Phenylalanine
Amoxicillin/potassium clavulanate (Augmentin) dose adjustment
hepatic
renal
Ampicillin/ Sulbactam
Unasyn
Ampicillin/ Sulbactam (Unasyn) class
antibiotic, PCN
Ampicillin/ Sulbactam (Unasyn) dose
2:1 ratio.
Dosage recommendations are expressed as total grams of ampicillin/sulbactam
IM, IV: 1-2 g ampicillin as 1.5-3 g Unasyn® q6h
Ampicillin/ Sulbactam (Unasyn) contraindications
Hepatotoxicity has been reported. Monitor hepatic function at regular intervals
Ampicillin/ Sulbactam (Unasyn) dose adjustment
renal
Penicillin V potassium
formerly Pen VK
Penicillin V potassium (formerly Pen VK) class
antibiotic, PCN
Penicillin V potassium (formerly Pen VK) dose
PO:125-500mg Q6-8h
Penicillin V potassium (formerly Pen VK) contraindications
Prolonged use may result in fungal or bacterial superinfection
Penicillin V potassium (formerly Pen VK) dose adjustment
none
Piperacillin/ tazobactam
Zosyn
Piperacillin/ tazobactam (Zosyn) class
antibiotic, PCN
Piperacillin/ tazobactam (Zosyn) dose
Adult doses are expressed as the combined amount of piperacillin and tazobactam.
IV: 3.375 gm q6h or 4.5gm q6-8h (max 18 gm/day)
Piperacillin/ tazobactam (Zosyn) contraindications
Sodium content (2.84 mEq per gram of piperacillin) should be considered in patients requiring sodium restriction
Risk of nephrotoxicity is increased when piperacillin and tazobactam is given in combination with vancomycin
Piperacillin/ tazobactam (Zosyn) dose adjustment
renal
Rifaximin
Xifaxan
Rifaximin (Xifaxan) class
anitbiotic, Rifamycin
Rifaximin (Xifaxan) dose
Hepatic encephalopathy: 550 mg BID
IBS–diarrhea:
550 mg TID for 14 days
Traveler’s Diarrhea:
200 mg TID for 3 days
Rifaximin (Xifaxan) contraindications
Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy.
Rifaximin (Xifaxan) dose adjustment
none
sulfamethoxazole 800mg/ trimethoprim 160 PO
Bactrim
sulfamethoxazole 800mg/ trimethoprim 160 IV
Sulfatrim
sulfamethoxazole 800mg/ trimethoprim 160 (Bactrim, Sulfatrim) class
antibiotic, sulfonamide
sulfamethoxazole 800mg/ trimethoprim 160 PO (Bactrim) dose
PO: 1-2 double strength tab Q12-24h
sulfamethoxazole 800mg/ trimethoprim 160 IV (Sulfatrim) dose
IV: 8-20mg/kg/day (TMP component) divided Q6-12h
sulfamethoxazole 800mg/ trimethoprim 160 (Bactrim, Sulfatrim) contrindications
megaloblastic anemia due to folate deficiency;
infants <2 months (manufacturer’s labeling), infants <4 weeks (CDC 2009); marked hepatic damage or severe renal disease (if patient not monitored);
concomitant administration with dofetilide
sulfamethoxazole 800mg/ trimethoprim 160 (Bactrim, Sulfatrim) dose adjustment
renal
Tobramycin
Tobramycin, formerly Tobradex
Tobramycin (formerly Tobradex) class
antibiotic, aminoglycoside
Tobramycin (formerly Tobradex) dose
Conventional: 1 - 2.5 mg/kg/dose Q8 -12 h;
to ensure adequate peak concentrations early in therapy: 4-7 mg/kg/dose QD
Tobramycin (formerly Tobradex) contraindications
May cause neuromuscular blockade and respiratory paralysis; especially when given soon after anesthesia or neuromuscular blockers.
Ototoxicity is proportional to the amount of drug given and the duration of treatment. Tinnitus or vertigo may be indications of vestibular injury and impending bilateral irreversible damage. Discontinue treatment if signs of ototoxicity occur.
Tobramycin (formerly Tobradex) dose adjustment
renal
Gentamicin
formerly Garamycin
Gentamicin (formerly Garamycin) class
antibiotic, aminoglycoside
Gentamicin (formerly Garamycin) dose
Depends on condition
Conventional: IM, IV: 3-5 mg/kg/day in divided doses Q 8h
extended-interval dosing: IV: 5-7 mg/kg/day QD
Gentamicin (formerly Garamycin) contraindications
May cause neuromuscular blockade and respiratory paralysis; especially when given soon after anesthesia or neuromuscular blockers.
Ototoxicity is proportional to the amount of drug given and the duration of treatment. Tinnitus or vertigo may be indications of vestibular injury and impending bilateral irreversible damage. Discontinue treatment if signs of ototoxicity occur.
Gentamicin (formerly Garamycin) dose adjustment
renal
Levofloxacin
Formerly Levaquin
Levofloxacin (Levaquin) class
antibiotic, FQ
Levofloxacin (Levaquin) dose
PO,IV: 250-750mg daily
Levofloxacin (Levaquin) contraindications
[BBW]: Fluoroquinolones are associated with disabling and potentially irreversible serious adverse reactions that may occur together, including: tendinitis tendon rupture peripheral neuropathy and CNS effects.
Discontinue levofloxacin immediately and avoid use of fluoroquinolones in patients who experience any of these serious adverse reactions
Levofloxacin (Levaquin) dose adjustment
renal
Moxifloxacin
Moxifloxacin, Avelox (IV)
Moxifloxacin (Moxifloxacin, Avelox (IV)) class
antibiotic, FQ
Moxifloxacin (Moxifloxacin, Avelox (IV)) dose
PO, IV: 400mg QD
Moxifloxacin (Moxifloxacin, Avelox (IV)) contraindications
[BBW]: Fluoroquinolones are associated with disabling and potentially irreversible serious adverse reactions that may occur together, including: tendinitis tendon rupture peripheral neuropathy and CNS effects.
Discontinue moxifloxacin immediately and avoid use of fluoroquinolones in patients who experience any of these serious adverse reactions
Moxifloxacin (Moxifloxacin, Avelox (IV)) dose adjustment
none
ciprofloxacin
cipro
ciprofloxacin (cipro) class
antibiotic, FQ
ciprofloxacin (cipro) dose
PO
IV
PO: 250-750mg Q12h
IV: 400mg Q12h
ciprofloxacin (cipro) contraindications
[BBW]: Fluoroquinolones are associated with disabling and potentially irreversible serious adverse reactions that may occur together, including: tendinitis tendon rupture peripheral neuropathy and CNS effects.
Discontinue ciprofloxacin immediately and avoid use of fluoroquinolones in patients who experience any of these serious adverse reactions
ciprofloxacin (cipro) dose adjustment
renal
Clarithromycin
formerly Biaxin
Clarithromycin (formerly Biaxin ) class
antibiotic, macrolide
Clarithromycin (formerly Biaxin ) dose
PO: 250-500mg Q12h or 1000mg (two 500mg ER) QD
Clarithromycin (formerly Biaxin ) contraindications
Potentially significant interactions may exist with CYP3A4 metabolism including some statins
History of QT prolongation or ventricular arrhythmia
Clarithromycin (formerly Biaxin ) dose adjustment
renal
hepatic
Fidaxomicin
Dificid
Fidaxomicin (Dificid) class
antibiotic, macrolide
Fidaxomicin (Dificid) dose
C. diff: 200mg BID for 10 days
Fidaxomicin (Dificid) contraindications
Do not use for systemic infections; fidaxomicin systemic absorption is negligible.
Fidaxomicin (Dificid) dose adjustment
none
Azithromycin
Zithromax
Azithromycin (Zithromax) class
antibiotic, macrolide
Azithromycin (Zithromax) dose
IV: CAP
500mg QD for at least 3 days, then 500mg PO QD to complete 7-10 days tx
PO: 500mg on day 1 followed by 250mg QD x 4days
Azithromycin (Zithromax) contraindications
Altered cardiac conduction with potential QT prolongation
Conflicting data on increased cardiovascular mortality
Azithromycin (Zithromax) dose adjustment
renal
Clindamycin
Cleocin
Clindamycin (Cleocin) class
antibiotic, lincosamide
Clindamycin (Cleocin) dose
PO: 600-800 mg/day in 2 to 4 divided doses; up to 2400 mg/day in 4 divided doses may be given for severe infections
IM, IV: 600-2700 mg/day in 2 to 4 divided doses, up to 4,800 mg/day IV (in divided doses) has been used in life-threatening infections
maximum: 600 mg/dose IM
Clindamycin (Cleocin) dose adjustment
none
Clindamycin (Cleocin) dose adjustment
none
Doxycycline
Vibramycin
Doxycycline (Vibramycin)class
antibiotic, tetracycline
Doxycycline (Vibramycin) dose
Doxycycline is available as hyclate, monohydrate, and calcium salts. All doses are expressed as doxycycline base.
Oral: 100 to 200 mg/day in 1 to 2 divided doses.
IV: 100 mg every 12 hours
Doxycycline (Vibramycin) contraindications
May cause tissue hyperpigmentation, tooth enamel hypoplasia, or permanent tooth discoloration (more common with long-term use, but observed with repeated, short courses) when used during tooth development (last half of pregnancy, infancy, and childhood ≤8 years of age
IV form may cause phlebitis.
Doxycycline (Vibramycin) dose adjustment
none
Minocycline
CoreMino, Minocin, Minolirra, Solodyn, Ximino
Minocin (IV)
Minocycline (CoreMino, Minocin, Minolirra, Solodyn, Ximino, Minocin (IV)) class
antibiotic, tetracycline derivative
Minocycline (CoreMino, Minocin, Minolirra, Solodyn, Ximino, Minocin (IV)) dose
IV: 200 mg for 1 dose, then 100 mg q12h, max 400mg/day
PO: Initial: 200 mg for 1 dose; Maintenance: 100 mg every 12 hours; more frequent dosing intervals may be used (50 mg 4 times daily)
Acne
PO: 50 to 100 mg twice daily
Minocycline (CoreMino, Minocin, Minolirra, Solodyn, Ximino, Minocin (IV)) contraindications
Hyperpigmentation may occur in nails, bone, skin (including scar and injury sites), eyes, sclerae, thyroid, oral cavity, visceral tissue, and heart valves; skin and oral hyperpigmentation are independent of dose or administration duration.
Do not use during pregnancy.
Minocycline (CoreMino, Minocin, Minolirra, Solodyn, Ximino, Minocin (IV)) dose adjustment
renal
Mupirocin
Bactroban, Centany
Mupirocin (Bactroban, Centany ) class
antiobiotic, topical
Mupirocin (Bactroban, Centany ) dose
Apply to affected area three times per day
Elimination of MRSA colonization: Intranasal: Approximately one-half of the ointment from the single-use tube should be applied into one nostril and the other half into the other nostril twice daily (morning and evening) for 5 days
Mupirocin (Bactroban, Centany ) contraindications
some dosage forms may contain propylene glycol
Mupirocin (Bactroban, Centany ) dose adjustment
none
Chlorhexidine
Paroex, Peridex, Periogard
Chlorhexidine (Paroex, Peridex, Periogard) class
antibiotic, oral rinse
Chlorhexidine (Paroex, Peridex, Periogard) dose
Swish and spit for 30 seconds with 15 ml twice daily after brushing teeth
Chlorhexidine (Paroex, Peridex, Periogard) contraindications
Staining of oral surfaces
Chlorhexidine (Paroex, Peridex, Periogard) dose adjustment
none
Nitrofurantoin
Macodantin, Macrobid, Furadantin
Nitrofurantoin (Macodantin, Macrobid, Furadantin) class
antibiotic, Miscellaneous
Nitrofurantoin (Macodantin, Macrobid, Furadantin) dose
Nitrofurantoin is chemically available as nitrofurantoin macrocrystals and nitrofurantoin monohydrate. Two different preparations are available in the US: A combination of nitrofurantoin monohydrate and nitrofurantoin macrocrystals (Macrobid), which is typically dosed twice daily for the treatment of acute infections and a preparation that consists solely of nitrofurantoin macrocrystals (Furadantin, Macrodantin), which is typically dosed 4 times daily for the treatment of acute infections. Regardless of the formulation used, advise patients to administer with food to improve absorption.
Different dosing for prophylaxis versus active treatment
Macrodantin: 50-100mg once daily to 4 times per day (max 400 mg/day)
Macrobid: 100mg 1-2 times daily
Nitrofurantoin (Macodantin, Macrobid, Furadantin) contraindications
Due to the possibility of hemolytic anemia caused by immature erythrocyte enzyme systems (glutathione instability), the drug is contraindicated in pregnant patients at term (38 to 42 weeks gestation), during labor and delivery, or when the onset of labor is imminent; also contraindicated in neonates younger than 1 month of age.
Contraindicated in patients with a previous history of cholestatic jaundice or hepatic dysfunction associated with nitrofurantoin.
Nitrofurantoin (Macodantin, Macrobid, Furadantin) dose adjustment
renal
Metronidazole
Flagyl
Metronidazole (Flagyl) class
antibiotic, Miscellaneous amebicide
Metronidazole (Flagyl) dose
Anaerobic infections;
PO: 250-750 mg every 8-12 hours
IV: 500-750 mg every 6-8 hours
Metronidazole (Flagyl) contraindications
Concomitant alcohol consumption (disulfiram-like reactions); avoid alcoholic beverages or products containing propylene glycol during oral or injectable therapy and for at least 3 days after therapy.
Avoid in pregnancy (1st trimester)
Metronidazole (Flagyl) dose ajustment
none
Vancomycin
Vancocin, Firvanq
Vancomycin (Vancocin, Firvanq) class
antibiotic, glycopeptide
Vancomycin (Vancocin, Firvanq) dose
IV: 15 to 20 mg/kg/dose (rounded to the nearest 250 mg; usual maximum: 2 g/dose initially) every 8 to 12 hours
PO: 125 to 500 mg 4 times daily
Vancomycin (Vancocin, Firvanq) contraindications
Oral is ineffective for treating systemic infections due to lack of absorption
Vancomycin (Vancocin, Firvanq) dose adjustment
none
Cefazolin
formerly Ancef
Cefazolin (formerly Ancef) class
antibiotic, 1st generation cephalosporin
Cefazolin (formerly Ancef) dose
IV: 250mg-2g Q6-12h
Cefazolin (formerly Ancef) contraindications
Caution in patients with a history of seizure disorder; high levels, particularly in renal impairment, may increase risk of seizures
Cefazolin (formerly Ancef) dose adjustment
renal
Cephalexin
Keflex
Cephalexin (Keflex) class
antibiotic, 1st generation cephalosporin
Cephalexin (Keflex) dose
250 to 1,000 mg every 6 hours or 500 mg every 12 hours (maximum: 4 g/day)
Cephalexin (Keflex) contrainidcations
Positive direct Coombs tests and acute intravascular hemolysis have been reported. If anemia develops, discontinue use and work up for drug-induced hemolytic anemia
Cephalexin (Keflex) dose adjustment
renal
Cefoxitin
formerly Mefoxin
Cefoxitin (formerly Mefoxin ) class
antibiotic, 2nd generation cephalosporin
Cefoxitin (formerly Mefoxin ) dose
IM, IV: 1-2g Q6-8h
Cefoxitin (formerly Mefoxin ) contrainidcations
Pediatric ≥3 months of age, higher doses have been associated with an increased incidence of eosinophilia and elevated AST
Cefoxitin (formerly Mefoxin ) dose adjustment
renal
Cefuroxime
formerly Zinacef or Ceftin
Cefuroxime (formerly Zinacef or Ceftin ) class
antibiotic, 2nd generation cephalosporin
Cefuroxime (formerly Zinacef or Ceftin ) dose
PO: 250-500 BID
IV: 750-1.5g Q8h
Cefuroxime (formerly Zinacef or Ceftin ) contraindications
Tablets and oral suspension are not bioequivalent; do not substitute on a mg-per-mg basis
Cefuroxime (formerly Zinacef or Ceftin ) dose adjustment
renal
Cefdinir
Omnicef
Cefdinir (Omnicef) class
antibiotic, cephalosporin, 3rd generation
Cefdinir (Omnicef) dose
PO: 300mg BID or
600mg QD for 5-7days
Cefdinir (Omnicef) contraindications
Cases of reddish stools have been reported with cefdinir with iron-containing products due to the formation of a nonabsorbable complex in the GI tract
Cefdinir (Omnicef) dose adjustment
renal
Ceftriaxone
Formerly Rocephin
Ceftriaxone (Formerly Rocephin ) class
antibiotic, 3rd generation cephalosporin
Ceftriaxone (Formerly Rocephin ) dose
IM, IV: 1-2g Q12-24h
Ceftriaxone (Formerly Rocephin )contraindications
Hyperbilirubinemic neonates
Concurrent use with IV calcium containing solutions in neonates
Ceftriaxone (Formerly Rocephin ) dose adjustment
none
Cefepime
Maxipime
Cefepime (Maxipime) class
antibiotic, 4th generation cephalosporin
Cefepime (Maxipime) dose
IV: 1-2g Q8-12h
Cefepime (Maxipime) contraindications
Neurotoxicity: Severe neurological reactions reported, including seizures and nonconvulsive status epilepticus. Risk may be increased with renal impairment; ensure dose adjusted for renal function and discontinue therapy if neurotoxicity develops
Cefepime (Maxipime) dose adjustment
renal
Linezolid
Zyvox
Linezolid (Zyvox ) class
antibiotic, oxazolidinone
Linezolid (Zyvox ) dose
PO: 400-600mg Q12h
IV: 600mg Q12h
Linezolid (Zyvox ) contraindications
Serotonin syndrome: Symptoms of agitation, confusion, hallucinations, hyperreflexia, myoclonus, shivering, and tachycardia may occur with concomitant proserotonergic drugs (ex. SSRI, SNRI, tramadol) agents which reduce linezolid’s metabolism, or in patients with carcinoid syndrome. Avoid use in such patients unless clinically appropriate and under close monitoring
Linezolid (Zyvox ) dose adjustment
none
Meropenem
Merrem
Meropenem (Merrem) class
antibiotic, carbapenem
Meropenem (Merrem) dose
IV:500mg Q6h
or 1-2g Q8h
Meropenem (Merrem) contraindications
Use with caution in patients with renal impairment; dosage adjustment required with CrCl ≤50 mL/min. Increased seizure risk and thrombocytopenia have been reported in patients with renal impairment.
Meropenem (Merrem) dose adjustment
renal
Apixaban
Eliquis
Apixaban (Eliquis) class
anticoagulant, factor Xa inhibitor
Apixaban (Eliquis) dose
Nonvalvular atrial fibrillation: PO: 5 mg BID unless patient has any 2 of the following: Age ≥80 years
wt ≤60 kg
SCr ≥1.5 mg/dL
then reduce dose to 2.5 mg BID
Apixaban (Eliquis) contraindications
Apixaban (Eliquis) dose adjustment
renal
hepatic
Edoxaban
Savaysa
Edoxaban (Savaysa) class
anticoagulant, factor Xa inhibitors
Edoxaban (Savaysa) dose
PO: 60mg QD
Edoxaban (Savaysa) contraindications
If CrCl >95ml/min do not use
Edoxaban (Savaysa) dose adjustment
renal
Rivaroxaban
Xarelto
Rivaroxaban (Xarelto ) class
anticoagulant, factor Xa inhibitor
Rivaroxaban (Xarelto ) dose
2.5-20mg QD-BID with food (max 20mg QD)
Rivaroxaban (Xarelto ) contraindications
Avoid use with CrCl < 30ml/min or in severe hepatic failure
Bleeding
Rivaroxaban (Xarelto ) sdose adjusmtnet
renal and hepatic
Warfarin
Coumadin
Warfarin (Coumadin) class
anticoagulant, vitamin K antagonist
Warfarin (Coumadin) dose
2-10mg QD
Warfarin (Coumadin) contraindications
Hemorrhagic tendencies
Recent or potential surgery
Severe uncontrolled HTN
Pregnancy
Warfarin (Coumadin) dose adjustment
hepatic
Dabigatran
Pradaxa
Dabigatran (Pradaxa) class
anticoagulant, direct thrombin inhibitor
Dabigatran (Pradaxa) dose
150mg BID
Dabigatran (Pradaxa) contraindications
Dabigatran (Pradaxa) dose adjustment
renal
Enoxaparin
Lovenox
Enoxaparin (Lovenox) class
anticoagulant, LMWH
Enoxaparin (Lovenox) dose
px: 30mg BID or 40mg QD SQ
tx: 1mg/kg BID or 1.5mg/kg QD SQ
Enoxaparin (Lovenox) contraindications
Thrombocytopenia with positive test for antiplatelet antibodies with enoxaparin use
Hypersensitivity to pork products
Active major bleeding,
Enoxaparin (Lovenox)dose adjustment
renal
Heparin
Heparin
Heparin class
anticoagulant
Heparin dose
Thromboembolism prophylaxis
5000 units every 8-12 hours subcutaneously
Treatment of thromboembolism
80 units/kg IV push followed by continuous infusion of 18 units/kg/hour
Heparin contraindications
Severe thrombocytopenia
Uncontrolled active bleeding
Heparin dose adjustment
none
Prochlorperazine
Compro (rectal)
Oral formerly known as Compazine
Prochlorperazine (Compro (rectal), PO formerly Compazine)
class
antipsychotic, 1st generation, antiemetic
Prochlorperazine (Compro (rectal), PO formerly Compazine)
dose
Nausea and Vomiting
PO: 5-10 mg three to four times per day
(max 40 mg/day)
IV: 2.5-10 mg three to four times per day
Rectal: 25 mg bid
Prochlorperazine (Compro (rectal), PO formerly Compazine)
contraindications
Coma or CNS depressants
Altered cardiac conduction
Anticholinergic side effects
Extrapyramidal symptoms
Prochlorperazine (Compro (rectal), PO formerly Compazine)
dose adjustment
none
Haloperidol
Haldol
Haloperidol (Haldol) class
antipsychotic, 1st generation
Haloperidol (Haldol) dose
Psychosis: 0.5 to 5 mg in divided doses
Schizophrenia: IM: 2 to 5 mg in divided doses (20 mg/day)
Haloperidol (Haldol) coontraindications
May cause extrapyramidal symptoms (EPS), including pseudoparkinsonism, acute dystonic reactions, akathisia, and tardive dyskinesia
Haloperidol (Haldol) dose adjustment
none
Lurasidone
Latuda
Lurasidone (Latuda) class
antipsychotic, atypical 2nd generation
Lurasidone (Latuda) dose
Bipolar Depression
Initial 20 mg at bedtime, titrated up to 120 mg/day
Schizophrenia
Initial: 40 mg daily increased to 160 mg/day
Lurasidone (Latuda) contraindications
Increased mortality in elderly patients with dementia related psychosis
Use with caution in patients at risk of seizures
Guidelines recommend gradually tapering antipsychotics to avoid physical withdrawal symptoms
Lurasidone (Latuda) dose adjustment
renal
hepatic
Olanzapine
Zyprexa, Zyprexa Relprevv
Olanzapine (Zyprexa, Zyprexa Relprevv) class
Antipsychotic, atypical 2nd generation
Olanzapine (Zyprexa, Zyprexa Relprevv) dose
Short-acting injection: IM: Initial dose: 10 mg
PO: Initial: 5 mg in the evening; adjust as tolerated to usual range of 5 to 20mg daily (30mg/day)
Extended-release injection: IM: Note: Establish tolerance to oral olanzapine prior to changing to extended-release injection. Maximum dose: 300 mg every 2 weeks or 405 mg every 4 weeks
Olanzapine (Zyprexa, Zyprexa Relprevv) contraindications
Olanzapine (Zyprexa, Zyprexa Relprevv) dose adjustment
none
Risperidone
(Risperdal, Risperdal Consta “IM”, Perseris “SQ”)
Risperidone (Risperdal, Risperdal Consta “IM”, Perseris “SQ”) class
Antipsychotic, atypical 2nd generation
Risperidone (Risperdal, Risperdal Consta “IM”, Perseris “SQ”) dose
Oral: 0.25-3 mg daily (16mg/day)
IM: Initial: 25 mg every 2 weeks (50mg)
SQ: Usual dose: 90 or 120 mg once monthly
Risperidone (Risperdal, Risperdal Consta “IM”, Perseris “SQ”) contraindications
Increased risk of hyperglycemia and metabolic changes
Risperidone (Risperdal, Risperdal Consta “IM”, Perseris “SQ”) dose adjustment
hepatic
renal
Ziprasidone
Geodon
Ziprasidone (Geodon) class
Antipsychotic, atypical 2nd generation
Ziprasidone (Geodon) dose
Oral: 20-40mg twice daily with food. (80-100mg twice daily depending on indication
IM: 10 mg to 20 mg administered as required up to a maximum dose of 40 mg per day
Ziprasidone (Geodon)contraindications
Should be avoided in combination with other drugs that are known to prolong the QTc interval
Severe cutaneous adverse reactions
Ziprasidone (Geodon) dose adjustment
hepatic
Aripiprazole
Abilify, Abilify Maintena IM
Aripiprazole (Abilify, Abilify Maintena IM) class
Antipsychotic, Atypical, 2nd generation
Aripiprazole (Abilify, Abilify Maintena IM) dose
PO: 10-15mg daily (30mg/day)
IM, ER: 400mg once monthly (doses should be separated by ≥26 days)
Aripiprazole (Abilify, Abilify Maintena IM) contraindications
Aripiprazole (Abilify, Abilify Maintena IM) dose adjustment
none
Clozapine
Clozaril, FazaClo, Versacloz
Clozapine (Clozaril, FazaClo, Versacloz) class
Antipsychotic, Atypical, 2nd generation
Clozapine (Clozaril, FazaClo, Versacloz)dose
12.5mg daily or twice daily increased to 300-450 mg/day (max dose 900mg.day)
Clozapine (Clozaril, FazaClo, Versacloz) contraindications
Clozapine (Clozaril, FazaClo, Versacloz) dose adjustment
none
lithium
Lithobid
Lithium (Lithobid) class
antimanic Agent
Lithium (lithobid) dose
Monitor serum concentrations and clinical response (efficacy and toxicity) to determine proper dose
Bipolar Disorder
600-900 mg BID-TID initially then titrated to 900 to 1800 mg/day
Lithium (lithobid) contraindications
Severe cardiovascular or renal disease
Concurrent use with diuretics
Caution with sodium intake or high sodium excretion
Concurrent use with ACE-Inhibitors or (ARBs)
Use with caution in patients with thyroid disease; hypothyroidism may occur with treatment
Lithium (lithobid) dose adjustment
renal
Meclizine
Bonine, Feormerly Antivert
Meclizine (Bonine, Feormerly Antivert) class
Antihistamine/antiemetic, Histamine 1 antagonist, first generation
Meclizine (Bonine, Formerly Antivert) dose
Vertigo: 25-100mg/day in divided doses
Motion Sickness: 25 to 50 mg 1 hour before travel, repeat dose every 24 hours if needed
Meclizine (Bonine, Feormerly Antivert) contraindications
CNS depression
Caution in patients with glaucoma
Meclizine (Bonine, Feormerly Antivert) dose adjustment
none
Promethazine
Phenergan
Promethazine (Phenergan) class
Antihistamine/antiemetic, Histamine 1 antagonist, first generation
Promethazine (Phenergan) dose
Oral or Rectal: 25 mg at bedtime or 12.5 mg before meals and at bedtime
IV, IM: 25 mg, may repeat in 2 hours when necessary; switch to oral route as soon as feasible
Promethazine (Phenergan) CI
Coma or CNS depressants
Altered cardiac conduction
Anticholinergic side effects
Extrapyramidal symptoms
Promethazine (Phenergan) dose adjustments
none
Cetirizine
Zyrtec
Cetirizine (Zyrec) class
Antihistamine, Second generation H1 Histamine Antagonist
Cetirizine (Zyrtec) dose
10mg daily
Up to 40mg daily depending on condition and response
Cetirizine (Zyrtec) CI
May cause CNS depression, which may impair physical or mental abilities
Cetirizine (Zyrec) dose adjustment
renal
Fexofenadine
Allegra
Fexofenadine (Allegra) class
Antihistamine, H1 antagonist
Antihistamine/ Antiemetic, Histamine H1 Antagonist
Fexofenadine (Allegra) dose
60mg twice daily or 180mg daily
Antiemetic; IM: 25 to 100 mg/dose
Anxiety; PO 50-100 mg four times daily
Fexofenadine (Allegra) CI
Use caution in patients with severe renal dysfunction based on published studies and not manufacturer data.
Precaution in renal failure patients, manufacturer does not provide recommendation but some studies indicate a lower dose is necessary
Caution in patients with glaucoma
QT prolongation/torsades de pointes
Fexofenadine (Allegra) dose adjustment
none
Levocetirizine
Xyzal
Levocetirizine (Xyzal) class
Antihistamine, Histamine H1 Antagonist
Levocetirizine (Xyzal) dose
PO: 5mg QD
Levocetirizine (Xyzal) CI
May cause CNS depression, which may impair physical or mental abilities
Rebound pruritus may occur within several days after stopping cetirizine
Levocetirizine (Xyzal) dose adjustment
renal
Metoclopramide
Reglan
Metoclopramide (Reglan)class
Gastrointestinal, Prokinetic, antiemetic
Metoclopramide (Reglan) dose
PO: 10-20 mg 4 times per day
IV: 10-20mg over 1-2 minutes
Metoclopramide (Reglan) CI
Extrapyramidal symptoms (EPS)
Hyperprolactinemia
Neuroleptic malignant syndrome
Metoclopramide (Reglan) dose adjustment
none
Ondansetron
Zofran
Ondansetron (Zofran) class
Antiemetic, Selective 5-HT3 Receptor Antagonist
Ondansetron (Zofran) dose
IV: 8-16 mg/day
Ondansetron (Zofran) CI
QT prolongation (increase risk > 16mg at one dose)
Serotonin syndrome
Ondansetron (Zofran) dose adjustment
hepatic
Sumatriptan
Imitrex
Sumatriptan (Imitrex) class
Antimigraine, serotonin 5-HT receptor agonists
Sumatriptan (Imitrex) dose
Oral: 25-100mg as a single dose. May repeat dose in 2 hours. (200mg/day)
SQ: 6 mg (0.5 mL) subcutaneously (SC) with autoinjector; may repeat in 1 hour or more (12mg/24 hours)
Sumatriptan (Imitrex) CI
Cerebrovascular syndromes/stroke
Hemiplegic or basilar migraine
Ischemic heart disease
Uncontrolled hypertension
Severe hepatic impairment
Use within 24 hours of ergotamine derivatives or another 5HT1 agonist
Concurrent use with MAOI
Sumatriptan (Imitrex) dose adjustment
hepatic
Baclofen
Gablofen, Lioresal
Baclofen (Gablofen, Lioresal) class
skeletal muscle relaxant
Baclofen (Gablofen, Lioresal) dose
Oral: 5 mg three times daily, then 10 mg three times daily until optimal response. Range 40-80 mg daily
Intrathecal: 50 mcg for 1 dose every 4-8 hours. Do not exceed 100 mcg/24 hours
Baclofen (Gablofen, Lioresal) contraindication
[BBW] Abrupt withdrawal of intrathecal baclofen, has resulted in sequelae, multiple organ-system failure, and death. Prevention of abrupt discontinuation requires careful attention to programming and monitoring of infusion system, refill scheduling and procedures, and pump alarms
Baclofen (Gablofen, Lioresal) dose adjustment
renal
Carisoprodol
Soma
Carisoprodol (Soma) class
skeletal muscle relaxant
Carisoprodol (Soma) dose
250-350 mg three times daily and at bedtime
Carisoprodol (Soma) CI
Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence to carisoprodol (and its metabolite, meprobamate) may occur with prolonged use
Limit use to 2 to 3 weeks
Carisoprodol (Soma) dose adjustment
none
Cyclobenzaprine
Amrix, Fexmid
Cyclobenzaprine (Amrix, Fexmid) class
skeletal muscle relaxant
Cyclobenzaprine (Amrix, Fexmid) dose
ER: 15 mg once daily; some patients may require up to 30 mg once daily
IR: 5 mg three times daily; may increase up to 10 mg 3 times daily if needed
Cyclobenzaprine (Amrix, Fexmid) CI
Concurrent use of MAOI CHF Heart block Arrythmias Acute recovery after MI Hyperthyroidism
Cyclobenzaprine (Amrix, Fexmid) dose adjustment
hepatic